NYLIM
ANIP icon

New York Life Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

New York Life Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,127
Closed -$354K – 880
2024
Q1 		$354K Buy
+5,127
New +$310K ﹤0.01% 1272

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York Life Investment Management's ANIP Position: Q2 2024 in Review

New York Life Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 5,127 shares — an estimated $354K sold.

New York Life Investment Management first reported a position in ANIP in Q1 2024 and held it in 1 quarter. The position peaked at $354K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • New York Life Investment Management reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 5,127 ANI Pharmaceuticals shares in Q2 2024, an estimated $354K.
  • New York Life Investment Management first reported a position in ANI Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's ANI Pharmaceuticals position peaked at $354K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.